Parameter | Weeks after Trial | ||
1 W | 2 W | 3 W | |
WBC (109/L) (%) | 7.12 ± 1.15 | 7.09 ± 1.11 | 7.32 ± 1.62 |
RBC (1012/L) | 4.57 ± 0.52 | 4.58 ± 0.55 | 4.68 ± 0.45 |
Hemoglobin (g/L) | 138.22 ± 17.14 | 137.78 ± 17.54 | 141.22 ± 14.81 |
HCT% | 0.41 ± 0.05 | 0.41 ± 0.05 | 0.42 ± 0.04 |
MCV (fL) | 89.31 ± 4.20 | 89.79 ± 4.85 | 89.00 ± 4.65 |
MCH (pg) | 30.31 ± 2.04 | 29.77 ± 1.80 | 29.97 ± 1.70 |
MCHC (g/L) | 338.84 ± 12.48 | 330.89 ± 6.58 | 336.78 ± 7.03 |
Platelet (109/L) | 224.08 ± 37.66 | 221.23 ± 34.55 | 232.11 ± 35.33 |
PCT% | 0.20 ± 0.05 | 0.19 ± 0.03 | 0.21 ± 0.05 |
PDW (fL) | 16.23 ± 0.97 | 16.48 ± 0.45 | 16.36 ± 1.12 |
MPV (fL) | 8.98 ± 1.22 | 8.47 ± 0.62 | 9.36 ± 1.21 |
Lymphocytes (%) | 31.76 ± 7.65 | 31.54 ± 9.55 | 22.83 ± 7.45 |
Monocytes (%) | 7.15 ± 1.66 | 7.06 ± 2.23 | 6.69 ± 1.81 |
Neutrophils (%) | 58.43 ± 8.76 | 59.47 ± 7.54 | 56.22 ± 9.44 |
Eosinophils (%) | 2.17 ± 1.67 | 2.02 ± 1.67 | 1.79 ± 1.44 |
Basophils (%) | 0.46 ± 0.21 | 0.46 ± 0.30 | 0.38 ± 0.21 |
Lymphocytes (109/L) | 2.23 ± 0.56 | 2.17 ± 0.45 | 2.52 ± 0.38 |
Monocytes (109/L) | 0.49 ± 0.14 | 0.52 ± 0.13 | 0.47 ± 0.24 |
Neutrophils (109/L) | 4.15 ± 1.19 | 4.25 ± 1.22 | 4.02 ± 1.43 |
Eosinophils (109/L) | 0.14 ± 0.12 | 0.15 ± 0.21 | 0.14 ± 0.13 |
Basophils (109/L) | 0.03 ± 0.01 | 0.03 ± 0.02 | 0.03 ± 0.01 |